Stock Research: Charming Medical

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Charming Medical

NAQ:MCTA VGG205281089
n/a
  • Value
    1
  • Growth
    89
  • Safety
    Safety
    36
  • Combined
    39
  • Sentiment
    48
  • 360° View
    360° View
    n/a
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ANALYSIS: The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Charming Medical. The consolidated Growth Rank has a good rank of 89, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 89% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 1 means that the share price of Charming Medical is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 99% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 36, which means that the company has a riskier financing structure than 64% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 48, indicating professional investors are more pessimistic about the stock than for 52% of alternative investment opportunities. ...read more

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
1 n/a n/a n/a
Growth
89 n/a n/a n/a
Safety
Safety
36 n/a n/a n/a
Sentiment
48 n/a n/a n/a
360° View
360° View
n/a n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
n/a n/a n/a n/a
Opinions Change
n/a n/a n/a n/a
Pro Holdings
n/a n/a n/a n/a
Market Pulse
94 n/a n/a n/a
Sentiment
48 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
1 n/a n/a n/a
Growth
89 n/a n/a n/a
Safety Safety
36 n/a n/a n/a
Combined
39 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
3 n/a n/a n/a
Price vs. Earnings (P/E)
1 n/a n/a n/a
Price vs. Book (P/B)
1 n/a n/a n/a
Dividend Yield
1 n/a n/a n/a
Value
1 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
61 n/a n/a n/a
Profit Growth
57 n/a n/a n/a
Capital Growth
64 n/a n/a n/a
Stock Returns
96 n/a n/a n/a
Growth
89 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
3 n/a n/a n/a
Refinancing
26 n/a n/a n/a
Liquidity
92 n/a n/a n/a
Safety Safety
36 n/a n/a n/a

Similar Stocks

Discover high‑ranked alternatives to Charming Medical and broaden your portfolio horizons.

Perusahaan Perkebunan London Sumatra Indonesia

JKT:LSIP
Country: Hong Kong
Industry: Agricultural Products
Size: Medium
Full Stock Analysis

Tokyotokeiba

TYO:9672
Country: Japan
Industry: Leisure Facilities
Size: Medium
Full Stock Analysis

CK Asset Holdings

HKG:1113
Country: Hong Kong
Industry: Real Estate Development
Size: X-Large
Full Stock Analysis

Iida Group Holdings

TYO:3291
Country: Japan
Industry: Homebuilding
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: